- Home
- TECH vs TSI Comparison
TECH vs TSI Comparison
Compare TECH & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- TSI
- Stock Information
- Founded
- TECH 1976
- TSI 1987
- Country
- TECH United States
- TSI United States
- Employees
- TECH N/A
- TSI N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- TSI Investment Managers
- Sector
- TECH Health Care
- TSI Finance
- Exchange
- TECH Nasdaq
- TSI Nasdaq
- Market Cap
- TECH 8.0B
- TSI N/A
- IPO Year
- TECH 1989
- TSI N/A
- Fundamental
- Price
- TECH $50.78
- TSI $4.84
- Analyst Decision
- TECH Buy
- TSI
- Analyst Count
- TECH 8
- TSI 0
- Target Price
- TECH $81.14
- TSI N/A
- AVG Volume (30 Days)
- TECH 2.3M
- TSI 106.8K
- Earning Date
- TECH 05-07-2025
- TSI 01-01-0001
- Dividend Yield
- TECH 0.63%
- TSI 7.46%
- EPS Growth
- TECH N/A
- TSI N/A
- EPS
- TECH 0.98
- TSI N/A
- Revenue
- TECH $1,196,016,000.00
- TSI N/A
- Revenue This Year
- TECH $8.19
- TSI N/A
- Revenue Next Year
- TECH $8.85
- TSI N/A
- P/E Ratio
- TECH $51.85
- TSI N/A
- Revenue Growth
- TECH 4.46
- TSI N/A
- 52 Week Low
- TECH $46.44
- TSI $4.48
- 52 Week High
- TECH $85.57
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- TECH 42.06
- TSI 49.49
- Support Level
- TECH $46.01
- TSI $4.71
- Resistance Level
- TECH $53.54
- TSI $4.84
- Average True Range (ATR)
- TECH 3.36
- TSI 0.09
- MACD
- TECH 0.19
- TSI 0.00
- Stochastic Oscillator
- TECH 57.33
- TSI 76.67
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.